ClinicalTrials.gg
RecruitingNCT07216222Updated Oct 13, 2026

K08 VR Fear Conditioning

An interventional study of Deep Brain Stimulation in Anxiety and Fear, PTSD and Veteran, sponsored by University of California, Los Angeles. Recruiting at 1 site in United States. Open to participants aged 18 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-13.

Primary conditionStress Disorders, Post-TraumaticRegistry: Anxiety DisordersReclassifiedWhy we changed it
Registry
Anxiety Disorders — the first condition term the registry derived for this study.
ClinicalTrials.gg
Stress Disorders, Post-Traumatic
Why
  1. The registry often attaches Anxiety Disorders to studies about something else, and this study's title and listed conditions do not name it.
  2. The study's listed conditions name Stress Disorders, Post-Traumatic.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by University of California, Los Angeles · Not applicable, Interventional, and Basic science

How we know

From the registry’s dates

  • Registered 6 months after the study started (first participant enrolled Mar 2025, registered Sep 2025).
  • Started Mar 2025; still recruiting 1 year 8 months later.
Updated Oct 13, 2026Now RecruitingSite recruiting status changed+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
70
Allocation
Not applicable
Ages
18 Years to 70 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 18 studies in Stress Disorders, Post-Traumatic by University of California, Los Angeles — 4 open to participants now, 4 under way, none of them phase 3. Stress Disorders, Post-Traumatic · University of California, Los Angeles.

Planned enrollment
8th of 17
70 · median 60
Started
2025
with 1 other
No phase
13 of 18
3 open now
Registered
18th of 18
by date

Among the 18 studies in Stress Disorders, Post-Traumatic by University of California, Los Angeles, this one is the 8th largest by planned enrollment of the 17 interventional ones that give a count, is one of 2 that started in 2025, is one of 13 with no phase, and was the 18th registered.

Stress Disorders, Post-Traumatic

2,689 studies on the registry are indexed under Stress Disorders, Post-Traumatic; 605 are open to participants now.

Browse Stress Disorders, Post-Traumatic studies →

Open to participants now

4 of the 18 studies in Stress Disorders, Post-Traumatic by University of California, Los Angeles are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 4 open studies →

Where they have run

Who these studies take

Of the 416 Stress Disorders, Post-Traumatic studies recruiting now, 188 (45%) set no upper age limit and 202 (49%) stop at 75 or younger; 62 take children under 18; 88 take healthy volunteers.

This study: 18 Years to 70 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 18 studies in Stress Disorders, Post-Traumatic by University of California, Los Angeles, or all of them as a file.
02

Study summary

The goal of this clinical trial is to learn how people respond to fear-related experiences in a virtual reality (VR) environment. The study will also look at how brain activity and body responses are connected to learning and memory of fear. To do so, we recruit individuals who are already implanted with a Responsive Neurostimulator (RNS) device for the treatment of epilepsy. This research may help improve our understanding of anxiety disorders and how to better treat them in the future.

The main questions it aims to answer are: 1) How do people learn to associate certain cues in VR with feelings of fear or safety? 2) What brain and body responses happen during fear learning?

Participants will: 1) Wear a virtual reality headset and experience different environments and sounds, 2) Have their brain activity, heart rate, and sweating measured, and 3) Receive safe, mild electrical pulses through the RNS device during the study to help study fear learning. Participants will attend one or more study sessions, each lasting about 3-4 hours.

03

Conditions studied

  • Anxiety and Fear
  • PTSD
  • Veteran

Browse trials for

04

In context

Stress Disorders, Post-Traumatic Reclassified

2,689 studies on the registry are indexed under Stress Disorders, Post-Traumatic; 605 are open to participants now.

This study's planned enrollment of 70 is close to the median of 69 across 2,203 interventional studies indexed under Stress Disorders, Post-Traumatic.

Browse Stress Disorders, Post-Traumatic studies →

Lead sponsor

University of California, Los Angeles is the lead sponsor of 1,172 studies on the registry; 195 are open to participants now.

Of its 95 completed or terminated interventional studies of FDA-regulated products, 70 (74%) have results posted.

Compared within Stress Disorders, Post-Traumatic, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Anxiety Disorders. The counts are of registry records indexed under each term, refreshed daily. How we classify →

05

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Male
  • Female
  • Between 18 and 70 years of age
  • Adequate visual and auditory acuity to allow neuropsychological testing
  • Have undergone surgical placement of NeuroPace RNS System for the treatment of epilepsy or post-traumatic stress disorder

Exclusion criteria

Exclusion Criteria:

- History of traumatic brain injury

06

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
70 participants (estimated)

Study arms

  • Experimental
    All RNS Participants

    In this single-arm study, all participants will complete identical experimental conditions with simultaneous iEEG recordings (Recording Study) or iEEG stimulation (Stimulation Study).

    Device: Deep Brain Stimulation

Interventions

  • DeviceDeep Brain Stimulation

    Deep brain stimulation via the Responsive Neurostimulator (RNS) device.

07

What researchers measure

Primary outcomes

  1. Intracranial EEG activity

    Power in the theta band (\~3-12 Hz).

    Time frame: Baseline

  2. Skin conductance activity

    Electrodermal response during the fear conditioning experiment, as quantified by changes in electrical conductance between electrodes placed on the palm.

    Time frame: Baseline

  3. Heart rate

    Time frame: Baseline

08

Study locations

1 of 1 sites recruiting
09

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Undecided

10

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2025 (actual). Primary completion is estimated for Mar 2028, 36 months after the start.

Of 1,066 non-industry interventional studies with no phase under Stress Disorders, Post-Traumatic, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 53. This study's planned 36 months is close to that.

Counting every sponsor, half of 1,094 studies reached it within 35 months; a quarter within 17 and three quarters within 53.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 23, 2025
First posted
Oct 14, 2025
StartActual
Mar 1, 2025
Primary completionEst.
Mar 1, 2028
CompletionEst.
Feb 28, 2030
Last update
Oct 13, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Enrolling by invitation→Recruiting
changed Oct 13, 2026
Sites
UCLA Semel Institute for Neuroscience and Human Behavior is now Recruiting
Oct 13, 2026
Contact
Study contact now listed: added j•••@gmail.com · •••2423. See the current contact
Oct 13, 2026
Site contacts
Changed at 1 site. See the sites
Show the site
  • UCLA Semel Institute for Neuroscience and Human Behavior · Los Angeles, United StatesContact added a•••@gmail.com · •••2423
Oct 13, 2026
Show all 1 update
  1. Oct 13, 2026
    Enrolling by invitation→Recruiting
    UCLA Semel Institute for Neuroscience and Human Behavior is now Recruiting
    Contact Study contact now listed: added j•••@gmail.com · •••2423. See the current contact
    Site contacts Changed at 1 site. See the sites
    Show the site
    • UCLA Semel Institute for Neuroscience and Human Behavior · Los Angeles, United StatesContact added a•••@gmail.com · •••2423
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

11

Registry details

Key details

Study ID
NCT07216222
Collaborators
National Institute of Mental Health (NIMH), Duke University, VA Greater Los Angeles Healthcare System
Responsible party
Anthony Jang, MD (Principal Investigator, University of California, Los Angeles) — Principal investigator
First posted
Oct 14, 2025
Start date
Mar 1, 2025
Primary completion
Mar 1, 2028 (estimated)
Completion
Feb 28, 2030 (estimated)
Last update
Oct 13, 2026

Study contacts

Jonny Baham
Contact
jangresearchlab.ucla@gmail.com
424-242-2423

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion